This exceptional report contains the latest data describing the total number, concentration and value of wholesale operations, status and activity of leading retail pharmacy chains, providers of pharmaceuticals to hospitals and direct and online operations.
This document examines the outcomes related to Poland’s recent regulatory developments, planned and currently in place. It is accompanied by a separate Excel document, Database of independent pharmacy chains in Poland, which provides essential information about 100 top companies operating stores across the country. Readers will learn about both independent and franchise chains, as well as the total number of pharmacies as compared to Polish residents.
The report profiles the top pharmaceutical wholesalers on the Polish market, including data on market share, revenue, and strategic outlook. Location information is provided for each, resulting in wholesaler concentration updates. It explores a wide range of market-oriented topics, from pharmaceutical purchasing groups to commonly used wholesaler/pharmacy loyalty schemes and significant relationships between top companies.
This unique publication offers parallel
import totals for Poland’s leading pharmaceutical companies, examines direct distribution operations on this market and provides separate sales totals for top pharmaceutical companies maintaining online operations. It presents comprehensive forecasts for market segments and all types of distribution on Poland’s pharmaceutical market for the years 2014-2019.
Distribution on the pharmaceutical market Poland 2014, Development forecasts for 2014-2019 was created to support the business decision making processes of executive and marketing professionals involved in wholesale and retail distribution of pharmaceuticals in Poland. Past editions have also been successfully utilised by leading pharmacy chains, all types of distributors active on the market and logistics and investments specialists interested in the potential of this expanding market.
Clients have revealed that the publication is an important asset when planning the launch of a new distribution enterprise on Poland’s pharmaceutical market, expanding a current enterprise, assessing the competition, or locating prospective candidates for mergers and/or acquisitions.
READ MORE >
Note: Product cover images may vary from those shown